Specialty Pharma ApS: Financial statements 2025
CVR: 38476599
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Specialty Pharma ApS (CVR 38476599) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 216,735 and a net result of DKK -58,566 compared with DKK -53,758 the year before. That is an increase of 124.8% compared with the year before. Equity in the 2025 report amounted to DKK -17,816. The company had 1 employee in the financial year.
- Gross Profit
- DKK 216,735
- Profit/Loss
- DKK -58,566
- Equity
- DKK -17,816
- Total Assets
- DKK 85,835
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 217 t. | -59 t. | -18 t. | 1 |
| 2024 | - | 96 t. | -54 t. | 41 t. | 1 |
| 2023 | - | 293 t. | 81 t. | 95 t. | 1 |
| 2022 | - | 1 mio. | 41 t. | 14 t. | 1 |
| 2021 | - | 639 t. | -44 t. | -27 t. | 2 |
Official annual report
How creditworthy is Specialty Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Specialty Pharma ApS has published its annual report for 2024. Gross profit came to DKK 96,397, and the net result was DKK -53,758.
About Specialty Pharma ApS
Specialty Pharma ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Ulla Haaning Singapuri. The company is owned by Ulla Haaning Singapuri. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 216,735 and a net result of DKK -58,566 compared with DKK -53,758 the year before. Equity in the 2025 report amounted to DKK -17,816.